Broadfin Healthcare Master Fund Ltd, 10% Owner at AVADEL PHARMACEUTICALS PLC (AVDL), sold 261,000 shares at $10.80 ($2.8M) on 2017-06-22, disclosed to the SEC on 2017-06-26.
Open-market sale of $2.8M AVDL by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.80 | 100,000 | $1.1M | 38.8% |
| 2 | $10.60 | 161,000 | $1.7M | 61.2% |
| Total | $10.68 avg | 261,000 | $2.8M | 100% |
| Filing → |
| REPH | SELL | 2017-12-14 | $1.5M | — | Filing → |
| REPH | SELL | 2017-12-07 | $1.0M | — | Filing → |
| PETX | SELL | 2017-12-01 | $5.1M | — | Filing → |